Elizabeth Freas's Colleagues at QED Therapeutics
Elizabeth Freas's Contact Details
HQ
650-231-4088
650-231-4088
Location
Denver,Colorado,United States
Denver,Colorado,United States
Company
QED Therapeutics
QED Therapeutics
Elizabeth Freas's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Elizabeth Freas
Elizabeth Freas currently works for QED Therapeutics.
Elizabeth Freas's role at QED Therapeutics is Senior Clinical Trial Manager.
Elizabeth Freas's email address is ***@qedtx.com. To view Elizabeth Freas's full email address, please signup to ConnectPlex.
Elizabeth Freas works in the Research industry.
Elizabeth Freas's colleagues at QED Therapeutics are Hao Wang, Francesca Avogadri-Connors, Hiywot Takkele, Sherry Markle, Sudesh Kamath, Mag Sellakumaran, Kathleen Dm and others.
Elizabeth Freas's phone number is 650-231-4088